BACKGROUND: Studies have confirmed adverse outcome associated with transfusion of packed red blood cells (PRBCs) in trauma; however, little data are available regarding other blood product transfusion, such as fresh frozen plasma (FFP) and platelets. The objective of this study was to examine risk-adjusted outcome in trauma with stratification by blood product type. METHODS: Prospective data were collected daily for 1,172 consecutive trauma patients admitted to the intensive care unit (ICU) during a 2-year period, including transfusion rates of blood products (PRBCs, FFP, platelets). Outcome assessment included infection rate, ventilator days (Vdays), ICU and hospital length of stay (LOS), and mortality. RESULTS: Blood products were transfused in 786 (67%) patients. The study cohort had a mean age of 43 +/- 21 years and Injury Severity Score (ISS) of 24 +/- 13. Although the majority of patients were men, women were more likely to be transfused (p < 0.001). Mean transfusion rates of PRBCs (5.5 +/- 9.6 U), FFP (5.4 +/- 11.4), and platelets (3.7 +/- 11.1) were high. Univariate analysis identified that blood product transfusion (any type) was associated with a significantly greater infection rate (34% vs. 9.4%; p < 0.001), hospital LOS (18.6 vs. 9 days; p < 0.001), ICU LOS (13.7 vs. 7.4 days; p < 0.001), Vdays (12.9 vs. 6.3 days; p < 0.001), and mortality (19% vs. 8.3%; p < 0.001). Multivariate analysis (risk-adjusted for severity of injury by ISS, age, sex, and race, and stratified by blood product type) confirmed that risk of infection increased by 5%, and hospital LOS, ICU LOS, and Vdays increased by 0.64, 0.42, and 0.47 days, respectively, for every unit of PRBCs given. Risk of death increased by 3.5% for every unit of FFP transfused. CONCLUSION: There is a dose-dependent correlation between blood product transfusion and adverse outcome (increased mortality and infection) in trauma patients.
BACKGROUND: Studies have confirmed adverse outcome associated with transfusion of packed red blood cells (PRBCs) in trauma; however, little data are available regarding other blood product transfusion, such as fresh frozen plasma (FFP) and platelets. The objective of this study was to examine risk-adjusted outcome in trauma with stratification by blood product type. METHODS: Prospective data were collected daily for 1,172 consecutive traumapatients admitted to the intensive care unit (ICU) during a 2-year period, including transfusion rates of blood products (PRBCs, FFP, platelets). Outcome assessment included infection rate, ventilator days (Vdays), ICU and hospital length of stay (LOS), and mortality. RESULTS: Blood products were transfused in 786 (67%) patients. The study cohort had a mean age of 43 +/- 21 years and Injury Severity Score (ISS) of 24 +/- 13. Although the majority of patients were men, women were more likely to be transfused (p < 0.001). Mean transfusion rates of PRBCs (5.5 +/- 9.6 U), FFP (5.4 +/- 11.4), and platelets (3.7 +/- 11.1) were high. Univariate analysis identified that blood product transfusion (any type) was associated with a significantly greater infection rate (34% vs. 9.4%; p < 0.001), hospital LOS (18.6 vs. 9 days; p < 0.001), ICU LOS (13.7 vs. 7.4 days; p < 0.001), Vdays (12.9 vs. 6.3 days; p < 0.001), and mortality (19% vs. 8.3%; p < 0.001). Multivariate analysis (risk-adjusted for severity of injury by ISS, age, sex, and race, and stratified by blood product type) confirmed that risk of infection increased by 5%, and hospital LOS, ICU LOS, and Vdays increased by 0.64, 0.42, and 0.47 days, respectively, for every unit of PRBCs given. Risk of death increased by 3.5% for every unit of FFP transfused. CONCLUSION: There is a dose-dependent correlation between blood product transfusion and adverse outcome (increased mortality and infection) in traumapatients.
Authors: P Innerhofer; G Luz; L Spötl; P Hobisch-Hagen; W Schobersberger; M Fischer; W Nussbaumer; A Lochs; E Irschick Journal: Transfusion Date: 1999-10 Impact factor: 3.157
Authors: William P Robinson; Jeongyoun Ahn; Arvilla Stiffler; Edmund J Rutherford; Harry Hurd; Ben L Zarzaur; Christopher C Baker; Anthony A Meyer; Preston B Rich Journal: J Trauma Date: 2005-03
Authors: Christopher C Silliman; Ernest E Moore; Jeffrey L Johnson; Ricardo J Gonzalez; Walter L Biffl Journal: Shock Date: 2004-04 Impact factor: 3.454
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Robert W Taylor; Lisa Manganaro; Jacklyn O'Brien; Steven J Trottier; Nadeem Parkar; Christopher Veremakis Journal: Crit Care Med Date: 2002-10 Impact factor: 7.598
Authors: George Kasotakis; Nichole Starr; Erek Nelson; Bedabrata Sarkar; Peter Ashley Burke; Daniel George Remick; Ronald Gary Tompkins Journal: Eur J Trauma Emerg Surg Date: 2018-04-07 Impact factor: 3.693
Authors: Nicolas Cheynel; Julie Gentil; Marc Freitz; Patrick Rat; Pablo Ortega Deballon; C Bonithon Kopp Journal: World J Surg Date: 2011-07 Impact factor: 3.352
Authors: Phillip A Letourneau; Shibani Pati; Michael H Gerber; Fernando Jimenez; John B Holcomb Journal: J Surg Res Date: 2010-05-20 Impact factor: 2.192
Authors: Janet S Lee; Jason L Sperry; Juan B Ochoa; Derek Barclay; Rami Namas; Yoram Vodovotz; Matthew Randall Rosengart Journal: Shock Date: 2012-04 Impact factor: 3.454
Authors: Louis R Lewandowski; Amy C Weintrob; David R Tribble; Carlos J Rodriguez; Joseph Petfield; Bradley A Lloyd; Clinton K Murray; Daniel Stinner; Deepak Aggarwal; Faraz Shaikh; Benjamin K Potter Journal: J Orthop Trauma Date: 2016-03 Impact factor: 2.512
Authors: Carlos J Rodriguez; Amy C Weintrob; Jinesh Shah; Debra Malone; James R Dunne; Allison B Weisbrod; Bradley A Lloyd; Tyler E Warkentien; Clinton K Murray; Kenneth Wilkins; Faraz Shaikh; M Leigh Carson; Deepak Aggarwal; David R Tribble Journal: Surg Infect (Larchmt) Date: 2014-05-12 Impact factor: 2.150
Authors: Jon K Femling; Sonlee D West; Erik K Hauswald; Hattie D Gresham; Pamela R Hall Journal: J Trauma Acute Care Surg Date: 2013-04 Impact factor: 3.313